Orange Book product · Generic (ANDA)
ERYTHRA-DERM
ERYTHROMYCIN
At a glance
Feb 05, 1988
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 05, 1988
38 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ERYTHROMYCIN
Strength
2%
Dosage form
SOLUTION
Route
TOPICAL
TE code
AT
Application
ANDA 062687
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERYTHROMYCIN
- 1987ERYGELBrand (NDA)
NDA 050617 · MYLAN
- 1986ERYTHROMYCINBrand (NDA)
NDA 050610 · PADDOCK LLC
- 1985ERYC SPRINKLESBrand (NDA)
NDA 050593 · HOSPIRA
- 1985ERYCETTEBrand (NDA)
NDA 050594 · JOHNSON AND JOHNSON
- 1985AKNE-MYCINBrand (NDA)
NDA 050584 · BAUSCH
- —ERYCBrand (NDA)
NDA 050536 · DR REDDYS LABS SA
- —ILOTYCINBrand (NDA)
NDA 050368 · DISTA
- —ERYTHROMYCINBrand (NDA)
NDA 050532 · LILLY
- —STATICINBrand (NDA)
NDA 050526 · WESTWOOD SQUIBB
- 2017ERYTHROMYCINGeneric (ANDA)
ANDA 208100 · ENCUBE
- 2017ERYTHROMYCINGeneric (ANDA)
ANDA 208154 · ENCUBE
- 2010ERYTHROMYCINGeneric (ANDA)
ANDA 090215 · EPIC PHARMA LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
